Biomarkers in the Pathogenesis, Diagnosis, and Treatment of Systemic Sclerosis
Journal of Inflammation Research · 2023-10 · Volume 16 · 4633-4660
DOI: 10.2147/jir.s379815 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Inflammation Research, 2023-10. Verfasst von Maheswari Muruganandam und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Rheumatology and School of Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, U…. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 284 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Division of Rheumatology and School of Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.
ORCID-Profile: Wilmer L Sibbitt
Zitieren
APA
Muruganandam, M., Ariza-Hutchinson, A., Patel, R. A., & Sibbitt, W. L. (2023). Biomarkers in the Pathogenesis, Diagnosis, and Treatment of Systemic Sclerosis. Journal of Inflammation Research, Volume 16, 4633-4660. https://doi.org/10.2147/jir.s379815
Vancouver
Muruganandam M, Ariza-Hutchinson A, Patel RA, Sibbitt WL. Biomarkers in the Pathogenesis, Diagnosis, and Treatment of Systemic Sclerosis. Journal of Inflammation Research. 2023;Volume 16:4633-4660. doi:10.2147/jir.s379815
BibTeX
@article{Muruganandam2023,
author = {Muruganandam, Maheswari and Ariza-Hutchinson, Angie and Patel, Rosemina A and Sibbitt, Wilmer L},
title = {Biomarkers in the Pathogenesis, Diagnosis, and Treatment of Systemic Sclerosis},
journal = {Journal of Inflammation Research},
year = {2023},
volume = {Volume 16},
pages = {4633--4660},
doi = {10.2147/jir.s379815}
}
EUVIMED